Healthcare leads the charge with 3 stocks (BMRN, JAZZ, THC) recently rated strong buy by analysts. Enterprise tech also gains momentum following Tuesday upgrades for MSTR and HPE. Average price target upside exceeding 50% for these biotech names suggests significant near-term growth potential for investors. However, Monday downgrades for COIN and ON signal caution in high-valuation crypto and semiconductor sectors.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.